These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Behavioural effects of 8-OH-DPAT, a 5-HT1A agonist in rats and effects on the behaviour of antimanic drugs].
    Author: Uchitomi Y, Yamawaki S.
    Journal: Yakubutsu Seishin Kodo; 1987 Sep; 7(3):383-92. PubMed ID: 2894736.
    Abstract:
    Effects of lithium, carbamazepine, zotepine, and clonazepam were examined on the behaviour mediated by 5-HT1A receptor and at 5-HT1A binding sites in rats. Forepaw treading, one component of 5-HT behavioural syndrome following subcutaneous injections of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), was not altered by reserpine, p-chlorophenylalanine, or alpha-methyl-p-tyrosine; in reserpine-treated rats, it was antagonized only by spiperone or by (-)-propranolol. These results indicate that 8-OH-DPAT-induced forepaw treading is produced by the direct stimulation of 5-HT1A receptor postsynaptically and also that this behaviour is not mediated by monoaminergic neurons. Lithium, carbamazepine, and zotepine inhibited forepaw treading in untreated rats; only lithium and clonazepam inhibited it in reserpine-treated rats. After 14 days treatment, only lithium enhanced it while its enhancement was abolished by reserpine. Radioligand binding studies using [3H]-8-OH-DPAT demonstrated that zotepine possessed weak affinity for 5-HT1A receptor; others lacked affinity. These results from acute experiments suggest that all drugs tested have inhibitory effects on the 5-HT1A receptor function. These effects, however, were not mediated by 5-HT1A receptor. And it is also suggested that the 5-HT1A receptor function after chronic lithium treatment might be enhanced by monoaminergic systems transsynaptically.
    [Abstract] [Full Text] [Related] [New Search]